title: [Acromegaly in the elderly].
abstract: Multicentric registers such as The French Acromegaly Register provide data on rare disorders that are otherwise difficult to obtain, so avoiding extrapolation from limited data sets. This study focuses on clinical, hormonal and therapy characteristics of acromegaly in people over 70 years old. The objective was to compare this population with the youngest to disclose if the medical management was similar.
  
  
  METHODS
  The data were obtained from the 30 centres that have registered patients in the Acromegaly Register since 1999.
  
  
  RESULTS
  The register listed 644 acromegaly patients on 1st January 2005, of whom 68 (22 men and 46 women) were over 70 years old, independently of the diagnosis date of their disease. Their average age was 76.8 + or - 5 years (range: 70-95) and they had suffered from acromegaly for 11 + or - 6 years (compared to 7 years in those aged less than 70). Their BMI were similar. Diabetes and hypertension were more frequent than in younger acromegalic patients and in the general French population matched for age. Circulating GH and IGF-1 concentrations were lower than in the younger acromegalic patients on inclusion and 1 year after treatment. There was no significant difference in the tumor size. Only 44% of the patients over 70 underwent surgery, against 90% of patients under 70 years. However, the fractions of young and elderly patients with a controlled disease 1 year after inclusion were the same (51%).
  
  
  CONCLUSIONS
  In the limits of the use of register, these data reveal a high prevalence of diabetes and hypertension in the eldest acromegalic patients. Despite much less frequent surgical intervention, patients' disease under control is equivalent to the younger population 1 year after the initial interview, confirming the effectiveness of the choices of treatment.
authors.affiliation: Service d'endocrinologie et maladies métaboliques, HIA Bégin, 69, avenue de Paris, 94160 Saint-Mandé, France. oliver-dupuy2@wanadoo.fr
authors.forename: O
authors.initials: O
authors.lastname: Dupuy
authors.forename: P
authors.initials: P
authors.lastname: Petrossians
authors.forename: T
authors.initials: T
authors.lastname: Brue
authors.forename: I
authors.initials: I
authors.lastname: Morange
authors.forename: L
authors.initials: L
authors.lastname: Bordier
authors.forename: H
authors.initials: H
authors.lastname: Mayaudon
authors.forename: B
authors.initials: B
authors.lastname: Bauduceau
mesh_terms: D000172:Acromegaly / Q000150:complications / Q000453:epidemiology*; D000368:Aged; D000369:Aged, 80 and over; D015992:Body Mass Index; D048909:Diabetes Complications / Q000097:blood / Q000453:epidemiology; D005260:Female; D005602:France / Q000453:epidemiology; D006331:Heart Diseases / Q000097:blood / Q000453:epidemiology; D019382:Human Growth Hormone / Q000097:blood; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008297:Male; D012016:Reference Values; D012042:Registries; D014652:Vascular Diseases / Q000097:blood / Q000453:epidemiology
chemical_list: D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I